Browse > Article

Vitexin, an HIF-1α Inhibitor, Has Anti-metastatic Potential in PC12 Cells  

Choi, Hwa Jung (Department of Dental Pharmacology, School of Dentistry, Chonbuk National University)
Eun, Jae Soon (College of Pharmacy, Woosuk University)
Kim, Bang Geul (Institute of Oral Bioscience, Chonbuk National University)
Kim, Sun Yeou (Department of Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Jeon, Hoon (College of Pharmacy, Woosuk University)
Soh, Yunjo (Department of Dental Pharmacology, School of Dentistry, Chonbuk National University)
Publication Information
Molecules and Cells / v.22, no.3, 2006 , pp. 291-299 More about this Journal
Abstract
Vitexin, a natural flavonoid compound identified as apigenin-8-C-${\beta}$-D-glucopyranoside, has been reported to exhibit antioxidative and anti-inflammatory properties. In this study, we investigated its effect on hypoxiainducible factor-$1{\alpha}$ (HIF-$1{\alpha}$) in rat pheochromacytoma (PC12), human osteosarcoma (HOS) and human hepatoma (HepG2) cells. Vitexin inhibited HIF-$1{\alpha}$ in PC12 cells, but not in HOS or HepG2 cells. In addition, it diminished the mRNA levels of hypoxia-inducible genes such as vascular endothelial growth factor (VEGF), smad3, aldolase A, enolase 1, and collagen type III in the PC12 cells. We found that vitexin inhibited the migration of PC12 cells as well as their invasion rates, and it also inhibited tube formation by human umbilical vein endothelium cells (HUVECs). Interestingly, vitexin inhibited the hypoxia-induced activation of c-jun N-terminal kinase (JNK), but not of extracellular-signal regulated protein kinase (ERK), implying that it acts in part via the JNK pathway. Overall, these results suggest the potential use of vitexin as a treatment for diseases such as cancer.
Keywords
c-jun N-terminal Kinase; Hypoxia-inducible Factor-$1{\alpha}$; Vascular Endothelial Growth Factor; Vitexin;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 20  (Related Records In Web of Science)
연도 인용수 순위
1 Aquino, R., Morelli, S., Lauro, M. R., Abdo, S., Saija, A., et al. (2001) Phenolic constituents and antioxidant activity of an extract of Anthuriumversicolor leaves. J. Nat. Prod. 64, 1019−1023
2 Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88−91   DOI   ScienceOn
3 Hien, T. V., Huong, N. B., Hung, P. M., and Duc, N. B. (2002) Radioprotective effects of vitexina for breast cancer patients undergoing radiotherapy with cobalt-60. Integr. Cancer Ther. 1, 38-34; discussion 42−33   DOI
4 Hodges, T. W., Hossain, C. F., Kim, Y. P., Zhou, Y. D., and Nagle, D. G. (2004) Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-Odemethylmanassantin B are potent inhibitors of hypoxiaactivated HIF-1. J. Nat. Prod. 67, 767−771   DOI   ScienceOn
5 Ke, Q. and Costa, M. (2006) Hypoxia-inducible Factor-1 (HIF- 1). Mol. Pharmacol. 70, 1469−1480   DOI   ScienceOn
6 Kim, J. H., Lee, B. C., Kim, J. H., Sim, G. S., Lee, D. H., et al. (2005) The isolation and antioxidative effects of vitexin from Acer palmatum. Arch. Pharm. Res. 28, 195−202   DOI
7 Lee, E., Yim, S., Lee, S. K., and Park, H. (2002) Two transactivation domains of hypoxia-inducible factor-lalpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol. Cells 14, 9−15
8 McNally, D. J., Wurms, K. V., Labbe, C., Quideau, S., and Belanger, R. R. (2003) Complex C-glycosyl flavonoid phytoalexins from Cucumis sativus. J. Nat. Prod. 66, 1280−1283   DOI   ScienceOn
9 Osada, M., Imaoka, S., and Funae, Y. (2004) Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett. 575, 59−63   DOI
10 Rajakumar, A., Doty, K., Daftary, A., Harger, G., and Conrad, K. P. (2003) Impaired oxygen-dependent reduction of HIF- 1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 24, 199−208   DOI   ScienceOn
11 Semenza, G. L., Roth, P. H., Fang, H. M., and Wang, G. L. (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757−23763
12 Tsuzuki, Y., Fukumura, D., Oosthuyse, B., Koike, C., Carmeliet, P., et al. (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha $\rightarrow$ hypoxia response element $\rightarrow$ VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res. 60, 6248−6252
13 Zagorska, A. and Dulak, J. (2004) HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 51, 563−585
14 Tabakman, R., Jiang, H., Levine, R. A., Kohen, R., and Lazarovici, P. (2004) Apoptotic characteristics of cell death and the neuneuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia. J. Neurosci. Res. 75, 499−507   DOI   ScienceOn
15 Tomczyk, M., Gudej, J., and Sochacki, M. (2002) Flavonoids from Ficaria verna Huds. Z Naturforsch [C]. 57, 440−444
16 Soh, Y., Jeong, K. S., Lee, I. J., Bae, M. A., Kim, Y. C., et al. (2000) Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol. Pharmacol. 58, 535−541
17 Beitner-Johnson, D., Ferguson, T., Rust, R. T., Kobayashi, S., and Millhorn, D. E. (2002) Calcium-dependent activation of Pyk2 by hypoxia. Cell Signal. 14, 133−137   DOI   ScienceOn
18 Kwon, Y. W., Kwon, K. S., Moon, H. E., Park, J. A., Choi, K. S., et al. (2004) Insulin-like growth factor-II regulates the expression of vascular endothelial growth factor by the human keratinocyte cell line HaCaT. J. Invest. Dermatol. 123, 152−158   DOI   ScienceOn
19 Page, E. L., Robitaille, G. A., Pouyssegur, J., and Richard, D. E. (2002) Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277, 48403−48409   DOI   ScienceOn
20 Stetler-Stevenson, W. G. (1999) Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J. Clin. Invest. 103, 1237−1241   DOI   ScienceOn
21 Semenza, G. L. (2004) O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J. Appl. Physiol. 96, 1173-1177; discussion 1170−1172   DOI   ScienceOn
22 Vaupel, P. (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9 Suppl 5, 10−17
23 Li, Y. L., Ma, S. C., Yang, Y. T., Ye, S. M., and But, P. P. (2002) Antiviral activities of flavonoids and organic acid from Trollius chinensis Bunge. J. Ethnopharmacol. 79, 365−368
24 Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., et al. (2006) Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor 1$\alpha$. J. Biol. Chem. 281, 33095−33106   DOI   ScienceOn
25 Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59, 5830−5835
26 Wenger, R. H. (2002) Cellular adaptation to hypoxia: O2- sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB J. 16, 1151−1162   DOI   ScienceOn
27 Matou, S., Colliec-Jouault, S., Galy-Fauroux, I., Ratiskol, J., Sinquin, C., et al. (2005) Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor- 2 or vascular endothelial growth factor in vitro. Biochem. Pharmacol. 69, 751−759   DOI   ScienceOn
28 Fang, J., Xia, C., Cao, Z., Zheng, J. Z., Reed, E., et al. (2005) Apigenin inhibits VEGF and HIF-1 expression via PI3K/ AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 19, 342−353   DOI   ScienceOn
29 Hollander, A. P., Corke, K. P., Freemont, A. J., and Lewis, C. E. (2001) Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis Rheum. 44, 1540−1544   DOI   ScienceOn
30 Bos, R., van Diest, P. J., de Jong, J. S., van der Groep, P., van der Valk, P., et al. (2005) Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46, 31−36   DOI   ScienceOn
31 Hasebe, Y., Egawa, K., Yamazaki, Y., Kunimoto, S., Hirai, Y., et al. (2003) Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol. Pharm. Bull. 26, 1379−1383   DOI   ScienceOn
32 Conrad, P. W., Rust, R. T., Han, J., Millhorn, D. E., and Beitner- Johnson, D. (1999) Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J. Biol. Chem. 274, 23570−23576   DOI
33 Hou, R. C., Huang, H. M., Tzen, J. T., and Jeng, K. C. (2003) Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells. J. Neurosci. Res. 74, 123−133   DOI   ScienceOn
34 Zhou, Y. D., Kim, Y. P., Mohammed, K. A., Jones, D. K., Muhammad, I., et al. (2005) Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells. J. Nat. Prod. 68, 947−950   DOI   ScienceOn
35 Park, J. W., Chun, Y. S., and Kim, M. S. (2004) Hypoxiainducible factor 1-related diseases and prospective therapeutic tools. J. Pharmacol. Sci. 94, 221−232   DOI   ScienceOn
36 Krishnamachary, B., Berg-Dixon, S., Kelly, B., Agani, F., Feldser, D., et al. (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63, 1138−1143
37 Flamme, I., Krieg, M., and Plate, K. H. (1998) Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha. Am. J. Pathol. 153, 25−29   DOI   ScienceOn
38 Hossain, C. F., Kim, Y. P., Baerson, S. R., Zhang, L., Bruick, R. K., et al. (2005) Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1. Biochem. Biophys. Res. Commun. 333, 1026−1033   DOI   ScienceOn
39 Bussolati, B., Dunk, C., Grohman, M., Kontos, C. D., Mason, J., et al. (2001) Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol. 159, 993−1008   DOI   ScienceOn
40 Cejudo-Martin, P., Morales-Ruiz, M., Ros, J., Navasa, M., Fernandez- Varo, G., et al. (2002) Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients. Hepatology 36, 1172−1179   DOI
41 Chen, Y., Zhang, Y. X., Li, M. H., Zhao, W. M., Shi, Y. H., et al. (2005) Antiangiogenic activity of 11,11′-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola. Biochem. Biophys. Res. Commun. 329, 1334−1342   DOI   ScienceOn
42 Gaitan, E., Cooksey, R. C., Legan, J., and Lindsay, R. H. (1995) Antithyroid effects in vivo and in vitro of vitexin: a Cglucosylflavone in millet. J. Clin. Endocrinol. Metab. 80, 1144−1147